InCytu
Lincoln · Founded 2007
About InCytu
InCytu is a therapeutic device engineering company developing immunotherapeutic and tissue regeneration products to transform personalized medicine. Founded in 2007 and lead by a strong management team, the cornerstone of InCytu's transformative technology platform was developed by Prof. David Mooney at Harvard University. The Company's first products revolve around the Cellarium™ system, a family of intelligent bioresorbable materials which are formulated and programmed to manipulate the immune system or rapidly heal and regenerate damaged or diseased tissue.
Company Facts
- Founded: 2007
- Legal name: InCytu, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $5.1M
- Last round: Series Unknown (Jan 2012)
- Website: incytu.org
- Phone: +1 4013340400
Social Profiles
Canonical: https://fsome.com/organization/incytu-8350501 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.